MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.320
-0.050 (-1.48%)
At close: Nov 11, 2026, 4:00 PM EST
3.270
-0.050 (-1.51%)
After-hours: Nov 11, 2026, 5:53 PM EST
MiMedx Group Revenue
MiMedx Group had revenue of $62.28M in the quarter ending September 30, 2026, a decrease of -45.23%. This brings the company's total for the last twelve months to $303.73M, down -22.80% year-over-year. In the year 2025, MiMedx Group had annual revenue of $418.63M with 19.99% growth. That makes MiMedx Group the 14,463rd largest company in the world by revenue and 2,600th in the United States.
Revenue (ttm)
$303.73M
Revenue Growth
-22.80%
P/S Ratio
1.60
Revenue / Employee
$375,905
Employees
808
Market Cap
484.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 418.63M | 69.75M | 19.99% |
| Dec 31, 2024 | 348.88M | 27.40M | 8.52% |
| Dec 31, 2023 | 321.48M | 53.64M | 20.03% |
| Dec 31, 2022 | 267.84M | 25.82M | 10.67% |
| Dec 31, 2021 | 242.02M | -6.22M | -2.50% |
| Dec 31, 2020 | 248.23M | -51.02M | -17.05% |
| Dec 31, 2019 | 299.26M | -59.86M | -16.67% |
| Dec 31, 2018 | 359.11M | 37.97M | 11.82% |
| Dec 31, 2017 | 321.14M | 99.43M | 44.85% |
| Dec 31, 2016 | 221.71M | 34.42M | 18.38% |
| Dec 31, 2015 | 187.30M | 69.07M | 58.43% |
| Dec 31, 2014 | 118.22M | 59.04M | 99.77% |
| Dec 31, 2013 | 59.18M | 32.13M | 118.76% |
| Dec 31, 2012 | 27.05M | 19.29M | 248.60% |
| Dec 31, 2011 | 7.76M | 6.97M | 883.74% |
| Dec 31, 2010 | 788.87K | - | - |
| Mar 31, 2009 | - | - | - |
| Mar 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Phathom Pharmaceuticals | 274.88M |
| Orchestra BioMed Holdings | 31.21M |
| Ovid Therapeutics | 1.45M |
| Oculis Holding AG | 1.12M |
| Shattuck Labs | 1.00M |
| Neurogene | 925.00K |
| Avalo Therapeutics | 59.00K |
MDXG News
- 13 hours ago - MiMedx Group Transcript: Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum - Transcripts
- 5 days ago - MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 13 days ago - MiMedx price target lowered to $7 from $8 at Craig-Hallum - TheFly
- 13 days ago - MiMedx price target lowered to $7 from $8 at Mizuho - TheFly
- 14 days ago - MiMedx enters $25M patent license agreement with wound care competitor - TheFly
- 14 days ago - MiMedx Group Earnings Call Transcript: Q3 2026 - Transcripts
- 14 days ago - MiMedx Group Quarterly report: Q3 2026 - Filings
- 14 days ago - MiMedx Group Earnings release: Q3 2026 - Filings